Authors:
Krebs, B
Rauchenberger, R
Silke, R
Rothe, C
Tesar, M
Thomassen, E
Cao, MQ
Dreier, T
Fischer, D
Hoss, A
Inge, L
Knappik, A
Marget, M
Pack, P
Meng, XQ
Schier, R
Sohlemann, P
Winter, J
Wolle, J
Kretzschmar, T
Citation: B. Krebs et al., High-throughput generation and engineering of recombinant human antibodies, J IMMUNOL M, 254(1-2), 2001, pp. 67-84
Authors:
Ulvestad, E
Kanestrom, A
Madland, TM
Thomassen, E
Haga, HJ
Vollset, SE
Citation: E. Ulvestad et al., Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice, SC J IMMUN, 52(3), 2000, pp. 309-315
Citation: E. Thomassen et al., Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily, CYTOKINE, 11(6), 1999, pp. 389-399
Authors:
Haga, HJ
Thomassen, E
Johannesen, A
Krakenes, J
Citation: Hj. Haga et al., Neural compressive symptoms appearing during steroid treatment in a patient with intracranial lipoma, SC J RHEUM, 28(3), 1999, pp. 184-186
Authors:
Thomassen, E
Bird, TA
Renshaw, BR
Kennedy, MK
Sims, JE
Citation: E. Thomassen et al., Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1, J INTERF CY, 18(12), 1998, pp. 1077-1088